Cocrystal Pharma Inc
(NASDAQ : COCP)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Generic
symbolcompany%chnglast%shortavg$volume
AGNAllergan plc
0.76%185.612.8%$338.60m
TEVATeva Pharmaceutical Industries Limited Sponsored ADR
0.42%24.212.1%$264.94m
ZTSZoetis, Inc. Class A
-0.09%91.461.9%$239.40m
MYLMylan N.V.
0.79%38.153.2%$211.59m
TXMDTherapeuticsMD, Inc.
-2.88%5.3927.8%$14.16m
RDYDr. Reddy's Laboratories Ltd. Sponsored ADR
1.62%33.852.0%$11.19m
ABEOAbeona Therapeutics, Inc.
-3.29%13.257.9%$6.50m
TAROTaro Pharmaceutical Industries Ltd.
-0.15%107.466.3%$4.65m
KINKindred Biosciences, Inc.
-0.86%14.400.3%$2.92m
LFVNLifeVantage Corporation
3.04%11.543.3%$2.89m
PETXAratana Therapeutics, Inc.
-3.43%5.079.0%$1.45m
BSPMBioStar Pharmaceuticals, Inc.
-5.26%1.9811.8%$1.24m
JAGXJaguar Animal Health, Inc.
-1.92%0.910.7%$0.09m
CPHIChina Pharma Holdings, Inc.
-2.33%0.230.1%$0.03m

Company Profile

Cocrystal Pharma, Inc. is a clinical stage biotechnology company, which engages in discovering and developing novel antiviral therapeutics that target the replication machinery of hepatitis viruses, influenza viruses, and noroviruses. CC-31244 is a Phase 2a ready broad-spectrum novel non-nucleoside replication inhibitor of Hepatitis C. Phase 1b studies in Hepatitis C infected patients showed the largest reduction in viral load of any non-neoside inhibitor tested to date. The next step for CC-31244 is clinical trials as part of a cocktail for ultra-short therapy of 2 to 6 weeks. The lead candidate for influenza has advanced to IND-enabling studies. It is effective in animal models against both the pandemic and seasonal strains of influenza. In addition, the company has a pipeline of early preclinical programs. Cocrystal Pharma was founded on January 2, 2014 and is headquartered in Tucker, GA..